Claes Lassvik

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

Göran Walldius, Uno Erikson, Anders Olsson et al. · The American Journal of Cardiology · 1994 · 250 citations

Medicine, Cardiology, Preventive Medicine +11

Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication

M.R. Malinow, Claes Lassvik, Anna‐Karin Holm et al. · Journal of Internal Medicine · 1992 · 131 citations

Medicine, Internal Medicine, Physiology +4

Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication.

Ib Christian Klausen, Claes Lassvik, Lars Ulrik Gerdes et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1992 · 73 citations

Life Sciences, Biochemistry, Physiology +13

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report

Göran Walldius, Lars A. Carlson, Uno Erikson et al. · The American Journal of Cardiology · 1988 · 61 citations

Pharmacy, Cardiology, Pharmacotherapy +16

Cold Sensitivity After Replantation in Relation to Arterial Circulation and Vasoregulation

G Nylander, Eva Nylander, Claes Lassvik · Journal of Hand Surgery (European Volume) · 1987 · 60 citations

Medicine, Surgery, Amputation Rehabilitation +14